Aethlon Medical, Inc. (AEMD), a medical therapeutic company, on Friday provided an important update on its Hemopurifier device in relation to H5N1 avian influenza (Bird Flu).
This announcement comes as concerns grow over the spread of H5N1, with reports of 60 human cases across eight U.S. states and the recent declaration of a state of emergency in California.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com